Psoriasis: Cardiovascular risk factors and other disease comorbidities

Journal of Drugs in Dermatology

Volumn 7, Issue 4, 2008, Pages 373-377

  Wu, Ying ^a   Mills, Douglas ^b   Bala, Mohan ^a  

^a CENTOCOR INC   (United States)

^b Consumer Health Sciences ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFORMATION PROCESSING; MALE; MIDDLE AGED; PREVALENCE; PSORIASIS; PSORIATIC ARTHRITIS; RISK FACTOR; UNITED STATES;

ARTHRITIS, PSORIATIC; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; COMORBIDITY; DATA COLLECTION; DEPRESSION; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE; PSORIASIS; RISK FACTORS; UNITED STATES;

EID: 46749152651     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Greaves MW, Weinstein GD. Treatment of psoriasis. N Engl J Med. 1995;332:581-588.
2. Boehncke W-H, Prinz J, Gottlieb AB. Biologic therapies for psoriasis. A systematic review. J Rheumatol. 2006;33:1447-1451. (Pubitemid 44025168)
3. Berger EM, Gottlieb AB. Developments in systemic immunomodulatory therapy for psoriasis. Curr Opin Pharmacol. 2007; 7:434-444. (Pubitemid 47296657)
4. Schon MP, Boehncke W-H. Psoriasis. N Engl J Med. 2005;352: 1899-1912.
5. Linden KG, Weinstein GD. Psoriasis: current perspectives with an emphasis on treatment. Am J Med. 1999;107:595-605.
6. Langley RG, Krueger GG, Griffiths CE. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis. 2005; 64(suppl):ii18-ii23.
7. Gelfand JM, Neimann AL, Shin DB, et al. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296:1735-1741. (Pubitemid 44547793)
8. Poikolainen K, Karvonen J, Pukkala E. Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis. Arch Dermatol. 1999;135:1490-1493.
9. Mallbris L, Akre O, Granath F, et al. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol. 2004;19:225-230. (Pubitemid 38461682)
10. Mallbris L, Ritchlin CT, Ståhle M. Metabolic disorders in patients with psoriasis and psoriatic arthritis. Curr Rheumatol Rep. 2006; 8:355-363. (Pubitemid 44638828)
11. Robinson D, Bala M, Wu Y, Kimball A. Increased prevalence of cardiovascular risk factors among psoriasis patients - results from two large healthcare databases. J Am Acad Dermatol. 2006; 54(suppl):AB203.
12. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol. 1995;32:982-986.
13. Christophers E. Psoriasis - epidemiology and clinical spectrum. Clin Exp Dermatol. 2001;26:314-320. (Pubitemid 34204344)
14. Altobelli E, Maccarone M, Petrocelli R, et al. Analysis of health care and actual needs of patients with psoriasis: a survey on the Italian population. BMC Public Health. 2007;7:59.
15. Wakkee M, Thio HB, Prens EP, et al. Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis. 2007;190:1-9. (Pubitemid 44908334)
16. Neimann AL, Shin DB, Wang X, et al. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006;55:829-835. (Pubitemid 44556851)
17. Sommer DM, Jenisch S, Suchan M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res. 2006;298:321-328.
18. Kremers HM, McEvoy MT, Dann FJ, Gabriel SE. Heart disease in psoriasis. J Am Acad Dermatol. 2007;57:347-354. (Pubitemid 47048862)
19. Mrowietz U, Elder T, Barker J. The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients. Arch Dermatol Res. 2006;298:309-319.
20. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415-1428. (Pubitemid 40523737)
21. National Health and Wellness Survey. Available at: http:// www.chsinternational.com/survey. Accessed November 25, 2007.
22. Gupta MA, Gupta AK, Schork NJ, Ellis CN. Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria. Psychosom Med. 1994;56: 36-40. (Pubitemid 24054871)
23. Wahl AK, Gjengedal E, Hanestad BR. The bodily suffering of living with severe psoriasis: in depth interviews with 22 hospitalized patients with psoriasis. Qual Health Res. 2002;12:250-261.
24. Gisondi P, Tessari G, Conti A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol. 2007;157:68-73. (Pubitemid 46934281)
25. Wilson PWF, D'Agostino RB, Parise H, et al. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2007;112:3066-3072.
26. Lindegard B. Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes. Dermatologica. 1986;172:298-304. (Pubitemid 16014779)
27. Kimball AB, Jacobson C, Weiss S, et al. The psychosocial burden of psoriasis. Am J Clin Dermatol. 2005;6:383-392. (Pubitemid 43128290)
28. Rapp SR, Feldman SR, Exum ML, et al. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999;41:401-407. (Pubitemid 29418506)
29. Gladmann DD, Antoni C, Mease P, et al. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis. 2005;64(suppl):ii14- ii17.